Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon. 1986

K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch

Phosphonoformate and recombinant alpha-A interferon synergistically inhibited the replication of human T-cell lymphotropic virus type III in cultured peripheral blood lymphocytes. T-cell proliferative capability was maintained by this combination, and toxicity was minimal.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010746 Phosphonoacetic Acid A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent. Phosphonoacetate,Disodium Phosphonoacetate,Fosfonet Sodium,Phosphonacetic Acid,Phosphonoacetate, Disodium
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D017245 Foscarnet An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. Phosphonoformate,Phosphonoformic Acid,Foscarnet Barium (2:3) Salt,Foscarnet Calcium (2:3) Salt,Foscarnet Disodium Salt,Foscarnet Magnesium (2:3) Salt,Foscarnet Manganese (2+) (2:3) Salt,Foscarnet Sodium,Foscarnet Sodium Hexahydrate,Foscarnet Trilithium Salt,Foscarnet Tripotassium Salt,Foscarnet Trisodium Salt,Foscavir,Trisodium Phosphonoformate

Related Publications

K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
June 1985, Lancet (London, England),
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
February 1987, Antimicrobial agents and chemotherapy,
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
December 1986, Antimicrobial agents and chemotherapy,
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
June 2007, European cytokine network,
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
May 1991, Antiviral research,
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
September 2001, Journal of virology,
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
June 1990, The Journal of infectious diseases,
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
January 1987, Hematologic pathology,
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
February 2005, Virology journal,
K L Hartshorn, and E G Sandstrom, and D Neumeyer, and T J Paradis, and T C Chou, and R T Schooley, and M S Hirsch
July 2013, AIDS research and human retroviruses,
Copied contents to your clipboard!